CIRTRAN CORP

EFFECT effective

S-1/A amended

S-1 filed

424B3 priced

CirTran Corporation's 424B3 filing registers the resale of up to 100,000,000 shares of common stock by Highgate House Funds, Ltd., a selling shareholder. The shares are issuable upon conversion of a 5% Secured Convertible Debenture, with conversion terms tied to stock price thresholds. The company does not receive proceeds from the resale, and Highgate may be deemed an underwriter. The filing highlights risks including market volatility, limited authorized shares, and reliance on the selling shareholder.

EFFECT effective

CIRTRAN CORP's current filing marks the effectiveness of its SB-2 registration statement on August 11, 2006, following the withdrawal of a prior registration statement (File No. 333-117466) in 2004. The company terminated a standby equity facility in 2005 without issuing shares or drawing funds, and the new filing includes responses to SEC comment letters from 2004 and 2005. The previous RW filing detailed the withdrawal of the 2004 registration and the company's intent to address regulatory feedback.

RW withdrawn

CirTran Corporation is withdrawing its previously filed Registration Statement on Form SB-2, which was part of a standby equity financing transaction. The company terminated the standby equity facility in May 2005 without drawing funds or issuing shares. The registration statement was never declared effective by the SEC, and no shares were sold. The company is now addressing SEC comment letters related to prior filings and plans to respond to the 2005 comment letter.

RW withdrawn

CirTran Corporation is withdrawing its previously filed Registration Statement on Form SB-2 (File No. 333-117466) from July 2004, which was related to a standby equity financing transaction. The Standby Facility was terminated in May 2005 without any funds being drawn or shares issued. The Registration Statement was never declared effective by the SEC. The company references prior SEC comment letters (2004 and 2005) and plans to address them in future filings.

424B3 priced

Price $0.00 · Range $0.00 to $0.00 · 252,562,500 shares · Gross proceeds $252,563

CirTran Corporation is offering the resale of 252,562,500 shares of common stock by Selling Shareholders, including Cornell Capital Partners, LP (Equity Line Investor), Westrock Advisors, Inc., and Butler Gonzalez LLP. The company will not receive proceeds, and the Equity Line Investor serves as an underwriter. The offering highlights risks related to operational losses, liquidity, and reliance on equity financing. A new Standby Equity Distribution Agreement (SEDA) was entered into on May 21, 2004, enabling additional draws up to $20 million.

424B3 priced

CirTran Corporation is offering up to 252,562,500 shares of common stock through three selling shareholders: Cornell Capital Partners, LP (Equity Line Investor), Westrock Advisors, Inc., and Butler Gonzalez LLP. The company will not receive proceeds from the sale, and the Equity Line Investor acts as an underwriter. The offering relates to shares issued under an equity line of credit agreement, with prior draws totaling $2.08 million as of April 2004.

424B3 priced

CirTran Corporation is offering the resale of 252,562,500 shares of common stock by three shareholders: Cornell Capital Partners, LP (Equity Line Investor), Westrock Advisors, Inc., and Butler Gonzalez LLP. The company will not receive proceeds from the sale, and the Equity Line Investor acts as an underwriter. The offering highlights significant operational risks, including historical losses, liquidity issues, and dependence on a private equity line of credit.

424B3 priced

Price $0.00 · Range $0.00 to $0.00 · 252,562,500 shares · Gross proceeds $252,563

CirTran Corporation is registering 252,562,500 shares of common stock for resale by three selling shareholders: Cornell Capital Partners, LP (Equity Line Investor), Westrock Advisors, Inc., and Butler Gonzalez LLP. The company will not receive proceeds from the sale. The filing relates to a secondary offering under a new equity line of credit agreement with Cornell Capital, which replaced a terminated 2002 agreement. The previous registration statement (SB-2) was withdrawn in April 2003 due to renegotiations.

RW withdrawn

CirTran Corporation is requesting to withdraw its SB-2 registration statement for a secondary offering due to the termination of an equity line agreement with a third-party investor. The company and investor intend to renegotiate terms and may file a new registration statement for resales under a revised agreement. No shares were issued or sold under the original registration, which was never declared effective by the SEC.

RW withdrawn

CirTran Corporation is requesting to withdraw its SB-2 registration statement for a secondary offering of common stock. The withdrawal is primarily due to the company's shares becoming eligible for resale under Rule 144, eliminating the need for the public float to qualify for OTCBB quotation. The company also plans to pursue a private offering under Rule 155(c). No shares were sold under the SB-2 registration, though 532,760 shares were sold via Rule 144 prior to the filing.